Prima, Trillium Therapeutics deal

Trillium acquired PRR's Arthron subsidiary for $500,000 in cash and 1.2 million Trillium shares, which represents a 7% stake in the company. PRR is slated to receive an additional $75,000 in cash from Trillium next month and is eligible to receive up to a 19% equity stake in Trillium if certain milestones are met. ...